Clinical Trial Applications - Approved: Filter, Search, and view applications


Clear
Extended search...

Page 20 of 59, showing 10 Applications out of 581 total, starting on record 191, ending on 200

# Protocol No Study Title Investigator(s) & Site(s) Date Approved

191.

ECCT/15/02/03   IVERMAL study
    Efficacy and safety of high-dose Ivermectin for reducing malaria transmission: A dose finding study   
Principal Investigator(s)
1. Menno Roderick Smit
Site(s) in Kenya
1. Jaramogi Oginga Odinga Teaching and Referral Hospital (JOOTRH) (Kisumu county)
2. Kisumu District Hospital (KDH), (Kisumu county)
3. Siaya District Hospital (Siaya county)
4. Vihiga District Hospital (Vihiga county)
 
26-03-2015 View

192.

ECCT/25/09/03   PRESERVE
    Partial breast re-irradiation using ultra hypofractionation (PRESERVE) Phase 2 multi-institutional study   
Principal Investigator(s)
1. Angela Waweru
Site(s) in Kenya
Aga Khan University Hospital
 
09-02-2026 View

193.

ECCT/23/04/05   BiMVaC01
    A randomised, controlled clinical trial to assess and compare the immunogenicity, safety and reactogenicity of the bivalent Omicron BA.4/BA.5 adapted, and the original Wuhan-Hu-1-strain, BNT162b2 COVID-19 vaccine formulations in healthy unvaccinated East African adults.   
Principal Investigator(s)
1. NDUNGU FRANCIS
2. Said Jongo
Site(s) in Kenya
KEMRI-CGMRC Kilifi
 
06-07-2023 View

194.

ECCT/25/08/07   ACCEDE Usability Study
    USABILITY, ACCEPTABILITY, FEASIBILITY AND COST OF CONTINUOUS GLUCOSE MONITORING BY PERSONS LIVING WITH TYPE 1 DIABETES MELLITUS, HEALTH CARE PROVIDERS AND CAREGIVERS AT THE PAEDIATRIC AND ADOLESCENT ENDOCRINOLOGY CLINIC IN KENYATTA NATIONAL HOSPITAL   
Principal Investigator(s)
1. Prisca Amolo
Site(s) in Kenya
Kenyatta National Hospital
 
10-12-2025 View

195.

ECCT/12/10/01   REMEMBER STUDY
    Reducing Early Mortality and Early Morbidity by Empiric Tuberculosis Treatment Regimens   
Principal Investigator(s)
1. Lucy N/A Koech
Site(s) in Kenya
1. KEMRI/WRP Kericho (Kericho county)
2. AMPATH Moi University Eldoret (Kericho county)
 
05-12-2012 View

196.

ECCT/22/09/02   LISA Trial
    Levonorgestrel intrauterine system effects on hemoglobin and serum ferritin among anemic women in Kenya: An open label randomized trial to compare with an oral contraceptive regimen that provides supplemental ferrous fumarate tablets   
Principal Investigator(s)
1. Faith Mugure Thuita
Site(s) in Kenya
Kangemi Health Centre
 
23-02-2023 View

197.

ECCT/25/02/11   Extended Dosing OCV Trial
    A Phase IV Parallel-Group, Open-Label, Randomized Non-Inferiority Trial Evaluating Immunogenicity of Extended Dosing Intervals for Euvichol-S Oral Cholera Vaccine, Nairobi, Kenya   
Principal Investigator(s)
1. Samuel Kariuki
Site(s) in Kenya
MMM MUKURU HEALTH CENTRE
 
16-07-2025 View

198.

ECCT/25/04/02   PRETERM AFRICA STUDY
    Pragmatic Evaluation of Therapies to Enhance Respiratory Management in Preterm Infants in Africa   
Principal Investigator(s)
1. Justus Simba
Site(s) in Kenya
1. Mama Lucy Kibaki Hospital (Nairobi City county)
 
10-03-2026 View

199.

ECCT/25/04/03   PRETERM AFRICA STUDY
    Pragmatic Evaluation of Therapies to Enhance Respiratory Management in Preterm Infants in Africa   
Principal Investigator(s)
1. Nayirat Mohamed
Site(s) in Kenya
1. Coast General Teaching and Referral Hospital (Mombasa county)
 
10-03-2026 View

200.

ECCT/25/06/01   Neosep1
    An open-label randomised controlled trial comparing novel combination and currently used antibiotic regimens for the empiric treatment of neonatal sepsis with a run-in confirmatory pharmacokinetic phase.   
Principal Investigator(s)
1. Christine Nafula Manyasi
Site(s) in Kenya
1. Mbagathi County Referral Hospital (Nairobi City county)
 
02-10-2025 View